Concord Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 ,inter alia, to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter and nine months period ended 31 December 2025.